Category Archives: E-Media

Forget Digital Differentiation: Focus on Cross-Channel 'Fusion'

By Guest Blogger | Published: April 17, 2013
Forget digital differentiation and innovation. You need to be focusing on cross-channel ‘fusion’, writes Peter Houston. Like you, I get invites to attend educational webinars on an almost daily basis; I probably actually attend one every couple of weeks. Most invites get passed over because it’s not my field, I’ve heard it all before or I don’t [...]
Also posted in Guest Blog, Technology, social media | Tagged , , , | 2 Comments

Changing the DNA of Pharma Patient Adherence Programs

By Guest Blogger | Published: March 12, 2013
by Grant Corbett Epigenetics is the study of changes in human gene expression, in particular from environmental factors.  Pharma is also experiencing epigenetic change.  Human genes are formed from DNA, which are instructions much like a blueprint.  Similarly, the environment is changing pharmaceutical DNA and how brand marketing is instructed.
Also posted in Marketing, Patient Communication, compliance, healthcare, patient compliance, patient education | Tagged , , , , , , | 3 Comments

Following Industry, OPDP Hopes to Eliminate Silos in Ad Review

By Ben Comer | Published: March 8, 2013
The Office of Prescription Drug Promotion (OPDP) is reorganizing its two primary advertising review divisions – professional and consumer – in an attempt to stay in line with the silo-breaking, multi-channel promotional output pouring in from pharma. The line between physician marketing and consumer marketing has blurred as the facets of a brand campaign – from [...]
Also posted in Advertising, FDA, Legal, Marketing, Patient Communication, Regulatory, Sales, compliance, patient education, social media | Tagged , , , | Leave a comment

ePharma Summit: Turning Big Data into Better Content

By Ben Comer | Published: March 6, 2013
Physicians and patients are more intimately engaged with their digital devices than ever before, but the content pharma delivers is either rigidly scientific or numbingly bland. Can stronger analytical processes and more data produce a scalable human voice for individual customers?
Also posted in Advertising, Events, FDA, Marketing, Patient Communication, Regulatory, Sales, Strategy, Technology, healthcare, multimedia, social media | Tagged , , , , | Leave a comment

Tom Abrams: Caronia Won't Stop Off-Label Enforcement

By Jill Wechsler | Published: January 30, 2013
The much-discussed US v. Caronia case, which has raised questions about the Food and Drug Administration prosecution of pharma companies for making off-label product claims, doesn’t change very much, according to FDA’s top drug marketing enforcer.
Also posted in Advertising, Agency Insight, FDA, Legal, Marketing, Regulatory, leadership, social media | Tagged , , , , , , , | 1 Comment